Back to RARE
VANGUARD GROUP INC RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
20
Latest value
$1.8M
Q4 2025
Peak value
$365.5M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $823K |
| Q1 2025 | $1.3M |
| Q1 2025 | $700K |
| Q1 2025 | $356.7M |
| Q1 2025 | $2.5M |
| Q2 2025 | $890K |
| Q2 2025 | $1.5M |
| Q2 2025 | $703K |
| Q2 2025 | $365.5M |
| Q2 2025 | $2.8M |
| Q3 2025 | $581K |
| Q3 2025 | $16.9M |
| Q3 2025 | $2.2M |
| Q3 2025 | $283.9M |
| Q3 2025 | $1.2M |
| Q4 2025 | $13.8M |
| Q4 2025 | $898K |
| Q4 2025 | $444K |
| Q4 2025 | $219.1M |
| Q4 2025 | $1.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $1.8M | 77.7K | — | — |
| Q4 2025 | $219.1M | 9.53M | — | — |
| Q4 2025 | $444K | 19.3K | — | — |
| Q4 2025 | $898K | 39.0K | — | — |
| Q4 2025 | $13.8M | 600.8K | — | — |
| Q3 2025 | $1.2M | 41.0K | — | — |
| Q3 2025 | $283.9M | 9.44M | — | — |
| Q3 2025 | $2.2M | 71.8K | — | — |
| Q3 2025 | $16.9M | 562.5K | — | — |
| Q3 2025 | $581K | 19.3K | — | — |
| Q2 2025 | $2.8M | 75.7K | — | — |
| Q2 2025 | $365.5M | 10.05M | — | — |
| Q2 2025 | $703K | 19.3K | — | — |
| Q2 2025 | $1.5M | 40.9K | — | — |
| Q2 2025 | $890K | 24.5K | — | — |
| Q1 2025 | $2.5M | 68.0K | — | — |
| Q1 2025 | $356.7M | 9.85M | — | — |
| Q1 2025 | $700K | 19.3K | — | — |
| Q1 2025 | $1.3M | 34.6K | — | — |
| Q1 2025 | $823K | 22.7K | — | — |
Other funds holding RARE
$213.3M
$205.6M
$205.6M
$155.5M
$148M
$133.1M
$120.9M